Holdsport News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

03.10.17	/R E P R I S E -- Invitation aux médias - Les ministres Proulx et Charbonneau seront à l'école secondaire De Rochebelle pour souligner la Semaine contre l'intimidation et la violence à l'école/ (PR Newswire)
17.05.17	Legion Capital Corporation Announces Initial Public Offering of Shares (PR Newswire)
14.08.15	Pfizer Receives Regulatory Approval In Canada For Pending Acquisition Of Hospira (RTTNews)
13.08.15	Pfizer Gets Regulatory Approval In Australia For Pending Acquisition Of Hospira (RTTNews)
05.08.15	European Commission Approves Acquisition Of Hospira By Pfizer (RTTNews)
29.07.15	Hospira Q2 Profit Beats Estimates (RTTNews)
15.05.15	FTC Seeks Additional Information On Pfizer's Proposed Acquisition Of Hospira (RTTNews)
12.02.15	Hospira Q4 Adj. Profit Tops View, Sales Match (RTTNews)
12.02.15	Hospira Q4 Profit Rises, Tops View - Quick Facts (RTTNews)
06.02.15	ACT Does A Balancing Act, HSP Snapped Up, PTLA, RXDX Up After-Hours (RTTNews)
05.02.15	Hospira Stock Shoots Up (RTTNews)
05.02.15	Pfizer Shares Climb In Pre-market (RTTNews)
12.01.15	Hospira Submits New Biologics License Application Biosimilar Retacrit (RTTNews)
30.12.14	Hospira Obtains FDA Approval Of Proprietary Analgesic Dyloject Injection (RTTNews)
21.08.14	Judge Grants Temporary Stay On Sale Of Generic's Of Hospira's Precedex (RTTNews)
31.07.14	CytoDyn On Watch List, FDA Panel Snubs EDAP, CRY Makes Investors Smile (RTTNews)
30.07.14	Hospira Boosts 2014 Outlook As Q2 Results Top Estimates (RTTNews)
30.07.14	Hospira Q2 Results Beat Estimates, Lifts FY14 Earnings View - Quick Facts (RTTNews)
04.07.14	Hospira Completes Acquisition Of Orchid's API Manufacturing And R&D Facility (RTTNews)
04.03.14	Hospira Appoints David Endicott As President, Hospira Medical Devices (RTTNews)
06.11.13	Hospira Q3 Profit Rises; Adj. Earnings Top Estimates; Backs FY13 Adj. EPS View (RTTNews)
22.10.13	Biosimilars Need Same Names as Original Biologics, Hospira Says at World Health Organization (WHO) Meeting (PR Newswire)
04.10.13	Events, Appointments, Approvals, Recommendations, and Agreements - Research Report on Elan, Alkermes, Hospira, pSivida, and Kindred (PR Newswire)
01.10.13	Technical Briefing: Celsion Corp., Theravance Inc., Alkermes PLC, and Hospira Inc. (PR Newswire)
10.09.13	Hospira's Inflectra™ (Infliximab) ist der erste biosimilare, monoklonale Antikörper, der in Europa zugelassen wird (PR Newswire)
10.09.13	Inflectra™ (infliximab) de la société Hospira représente le premier traitement biosimilaire par anticorps monoclonal à être approuvé en Europe (PR Newswire)
10.09.13	Hospira's Inflectra™ (infliximab) the first biosimilar monoclonal antibody to be approved in Europe (PR Newswire)
10.09.13	Hospira's Inflectra™ (infliximab) the first biosimilar monoclonal antibody to be approved in Europe (PR Newswire)
27.08.13	Today's Technical View: Alkermes plc, Hospira Inc., Celsion Corp., and Theravance Inc. (PR Newswire)
13.08.13	Hospira to Present at the Morgan Stanley Global Healthcare Conference (PR Newswire)
31.07.13	Hospira Reports Second-Quarter 2013 Results (PR Newswire)
22.07.13	Technical Study: Hospira, Alkermes, Theravance, and Celsion (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	91.64	0.68 %	K V
Nestle	77.88	0.67 %	K V
ABB	50.40	0.64 %	K V
Kuehne+Nagel Int	204.90	0.54 %	K V
Part Grp Hldg	1’414.00	0.53 %	K V
Holcim	95.70	-0.17 %	K V
Givaudan	3’821.00	-0.18 %	K V
UBS Group	30.22	-0.30 %	K V
Sika	231.40	-0.34 %	K V
Roche Hldg G	289.30	-0.45 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Holdsport Limited

Aktien Top/Flop

Meistgelesene Nachrichten